FDA issued a Warning Letter to OsteoSymbionics LLC on 11/30/2010 for a previous inspection.
483 OsteoSymbionics Mar 2017

483 OsteoSymbionics Mar 2017

Laureen Geniusz FDA$119.00 - Available Now

FDA investigators audited the OsteoSymbionics - Cleveland, OH, United States facility and issued inspectional observations (via FDA 483) on 29 Mar 2017.

Product details

  • Category: Medical Devices & Rad Health
  • Inspection end: 29 Mar 2017
  • Location: Cleveland, United States
  • FEI: 3007223102
Add To Cart